BLOG/🇺🇸United States··daily

S&P 500 Industrials Sector SEC Filings — March 31, 2026

USA S&P 500 Industrials

39 high priority11 medium priority50 total filings analysed

Executive Summary

Across 50 filings in the USA S&P 500 Industrials stream (broadly encompassing industrials-adjacent sectors like defense, energy services, and construction-related CMBS), a dominant theme is routine compliance in 20+ CMBS 10-Ks with widespread master servicer transitions from Wells Fargo to Trimont LLC effective March 1, 2025, signaling operational stability in commercial real estate financing. Period-over-period trends show mixed financials: revenue growth in 8/15 operating companies averaging +20% YoY (e.g., Dawson Geophysical +16%, Range Resources +11%), but persistent net losses or NAV declines in 7 cases (avg -20% equity/NAV drop); Adjusted EBITDA surges in turnarounds like TruBridge (+51% Patient Care) and Dawson (+139%). Positive M&A and capital allocation stand out, with Red Cat's drone acquisitions ($25M+ earnout), Oramed's asset sale with revenue sharing, Range Resources' $231M buybacks/$86M dividends, and First Northern's 6% share repurchase program (~$15.6M). Biotech/industrials crossovers like Tonix (Lyme Ph1 success) and Telomir (TNBC IND) add forward catalysts, while risks include Lipella bankruptcy and going concern doubts in EMAT. Portfolio-level, 65% neutral/positive sentiment, with cap alloc favoring returns over reinvestment; implications favor selective longs in defense/energy services amid stable RE backdrop.

Tracking the trend? Catch up on the prior S&P 500 Industrials Sector SEC Filings digest from March 25, 2026.

Investment Signals(12)

  • Completed subsidiary sale to Lifeward for 1.25M shares, warrants, and 4% rev share (up to 10yrs/$200M cap), concurrent $9M note investment

  • Teva Pharmaceuticals(BULLISH)

    2025 global rev +3% LC (ex-Japan divest), AUSTEDO +34%, AJOVY +30% to $673M, UZEDY +63% to $191M, net debt -8% to $13.3B

  • ICMB

    Total investment income +49.7% YoY to $17.4M, distributions +117% to $0.52/share despite NAV -21% [MIXED/BULLISH ON INCOME]

  • TruBridge(BULLISH)

    FY2025 rev +1% to $347M, net income turnaround +$25M to $4.4M profit, op income +227% to $20.8M, cash +102% to $24.9M

  • FY2025 fee rev +16% to $61.9M, Q4 +67% to $22.9M, Adj EBITDA +139% to $4.7M, op cash flow $14M

  • Positive Ph1 TNX-4800 Lyme data (4mo protection, half-life 62-69 days), adaptive Ph2 initiation H1 2027 pending FDA

  • IND filed for Telomir-1 TNBC therapy (tumor reduction, no toxicities), Ph1/2 trial post-clearance with dose-escalation

  • 2025 sales +11% to $2.8B, op cash $1.2B, net debt - $186M to 0.8x EBITDAX, $231M buybacks/$86M div

  • Acquired Quaze Technologies for $25M shares +$5M earnout (rev/margin targets), plus Apium swarm robotics businesses

  • FY2025 rev +∞ from $0 to $3.7M, net income +$29M to $19.2M gain (bargain purchase), assets +1,887% to $123M

  • New buyback auth 984k shares (6% o/s) ~$15.6M at $15.85, effective May 1 2026-Apr 30 2028

  • Monthly div $0.1315 (ann $1.60 target), record Apr 30/pay May 15 2026

Risk Flags(10)

  • ICMB[HIGH RISK]

    NAV/share -21.2% to $4.25, net assets -21% to $61M, unrealized losses $10.8M, shares at 28-48% NAV discount

  • TruBridge[MEDIUM RISK]

    Patient Care recurring rev -2% to $109M, total bookings flat at $83M YoY

  • Sales +10,857% to $767k but net loss +29% to $3.3M, cash -84% to $63k, equity deficit + to $6M

  • FinTrade Sherpa[MEDIUM RISK]

    Net loss +332% to $342k (no rev), op exps +332%, working capital defic ~$169k flat

  • FY2025 rev flat 0.02% YoY, net loss +33% to RMB48M (goodwill impair RMB34M), op loss +49%

  • SUIC Worldwide[MEDIUM RISK]

    First rev $18k but assets -88% to $9.8k, cash -78% to $8.6k, equity deficit +13% to $(878k)

  • No rev, net loss $22k, stockholders deficit $21k, reliant on stockholder note $29k

  • Chapter 11 bankruptcy filed Mar 30 2026, trading highly speculative/no recovery likely

  • EMAT (ex-Welsbach)[HIGH RISK]

    Multiple going concern doubts from auditors (EMAT/EM/subs), post-business combo Jan 2026

  • Range Impact[MEDIUM RISK]

    $79.3M future reclamation obligs from acquisitions, op cash modest +$123k despite asset surge

Opportunities(8)

Sector Themes(6)

  • CMBS Servicer Transitions(STABILITY THEME)

    18/20 CMBS 10-Ks report Wells Fargo to Trimont master servicer Mar 1 2025 (e.g., Potomac Mills, Opry Mills); neutral sentiment, no non-compliance – stable RE financing for industrials prop

  • Revenue Growth vs Loss Persistence(MIXED RECOVERY)

    8/15 ops cos rev +avg20% YoY (Dawson16%, Range Res11%, TruBridge1%) but 9/15 net losses/declines (avg equity -15%); cap alloc to returns (buybacks/divs 4 cos) over growth

  • M&A/Acquisitions Accelerating(CONSOLIDATION THEME)

    5 filings (Red Cat 2x drone tech $25M+, Oramed sub sale, Range Impact mines +150k acres, EMAT combo); valuations accretive (bargain gains), defense/mining focus

  • Cap Alloc Shareholder Focus(RETURN PRIORITY)

    4/50 emphasize returns – Range Res $317M buyback/div, First Northern 6% repurchase $15.6M, SmartStop $1.60 ann div, ICMB dist +117%; vs reinvest in 70% neutral CMBS

  • Forward Biotech/IND Catalysts(CATALYST PIPELINE)

    3 pharma (Tonix Ph2 H1'27, Telomir IND Ph1/2, Teva 4 biosimilars 2026-27); positive data/INDs amid industrials R&D crossover

  • Compliance Clean Sweep[LOW RISK THEME]

    100% CMBS attestations (33/34 series) no material non-comp (e.g., Sequoia 2013-7/4 positive); supports low vol in RE trusts tied to industrial properties

Watch List(8)

  • Teva Pharmaceuticals/AGM(MONITOR PROPOSALS)
    👁

    Virtual mtg May 28 2026 (rec Apr6), director election/NEO comp/auditor; biosimilars launches 2026-27

  • Range Resources/AGM(MONITOR CAP ALLOC)
    👁

    Virtual mtg May 13 2026 (rec Mar16), dir elections/exec comp; post strong 2025, watch debt/prod guidance

  • Tonix Pharmaceuticals/Ph2 Trial(FDA CLEARANCE CATALYST)
    👁

    Adaptive Lyme Ph2 init H1 2027 pend FDA; Ph1 data Mar30 2026

  • 👁

    TNBC Ph1/2 post-FDA IND clearance (filed Mar31 2026); preclinical biomarkers advancing

  • Quaze $25M deal cond'l reg approv/Nasdaq by Dec31 2026; Apium integration

  • Ch11 filed Mar30 2026; monitor stock spec trading/recovery prospects

  • Shareholder approval Mar30 2026 (99% for) w/Community West (Dec16'25 agr); close timeline [M&A COMPLETION]

  • EMAT/Going Concern(FINANCIAL STRESS)
    👁

    Post-combo Jan5 2026, multi-auditor doubts; monitor Q1 ops viability

Filing Analyses(50)
ORAMED PHARMACEUTICALS INC.8-Kpositivemateriality 9/10

31-03-2026

On March 25, 2026, Oramed Pharmaceuticals Inc. completed the sale of its wholly-owned subsidiary Oratech Pharma, Inc. to Lifeward Ltd. under a Share Purchase Agreement, receiving 1,250,363 Lifeward Ordinary Shares, 1,006,113 Pre-Funded Warrants (exercise price $0.0001 per share), Share Purchase Warrants for up to 1,296,296 shares (initial exercise $5.40), and 4% revenue sharing on Lifeward's ReWalk Personal Exoskeleton net revenues until the earlier of 10 years, reaching a maximum amount, or Lifeward's market cap hitting $200 million. Concurrently, Oramed closed a $9 million private placement purchase of senior secured convertible notes from Lifeward (initial conversion $5.40) plus warrants for 1,666,666 shares (initial exercise $5.40). No declines or flat performance metrics reported in this transactional update.

  • ·Revenue sharing payments end at earliest of 10 years post-closing, receipt of undefined Maximum Amount, or Lifeward market cap >= $200 million.
  • ·Notes and warrants have adjustment provisions; initial prices $5.40 per share.
  • ·Transaction initially announced January 12, 2026; prior 8-K filed January 14, 2026.
TEVA PHARMACEUTICAL INDUSTRIES LTDDEF 14Amixedmateriality 8/10

31-03-2026

Teva's 2026 Proxy Statement for the May 28, 2026 virtual annual meeting highlights execution of the Pivot to Growth strategy, with 2025 global revenues up 3% in local currency (excluding divested Japan venture), driven by AUSTEDO (+34%), AJOVY (+30% to $673M), and UZEDY (+63% to $191M), plus $500M milestone revenue from duvakitug Phase 3 initiation. However, global generics revenues declined 2% YoY including the Japan venture. Net debt improved to $13.3B from $14.5B, total debt to $16,807M from $17,783M, and 2025 transformation savings targets were met toward ~$700M through 2027.

  • ·Annual shareholder meeting: May 28, 2026 at 4:00 p.m. Israel time / 9:00 a.m. ET, virtual at www.meetnow.global/TEVA26; Record Date: April 6, 2026
  • ·Proposals: (1) Appoint Dr. Sol J. Barer as director until 2029 AGM (FOR); (2) Advisory approval of NEO compensation (FOR); (3) Appoint Kesselman & Kesselman (PwC) as auditor until 2027 AGM (FOR)
  • ·Biosimilars pipeline: 24 programs, 4 potential launches 2026-2027 subject to approvals
  • ·Net debt reduced by more than $20B over past 8 years
  • ·Olanzapine LAI NDA submitted Dec 9, 2025, FDA accepted Feb 2026; no post-injection delirium/sedation in Phase 3
  • ·Duvakitug Phase 3 initiated Oct 2025 for UC and Crohn's; Phase 2b positive Feb 2026
CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-P610-Kneutralmateriality 5/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-P6, filed March 31, 2026, contains numerous attestation reports (Form 34) and assessment reports (Form 33) from master servicers, special servicers, trustees, custodians, and operating advisors confirming compliance with servicing criteria for asset-backed securities across multiple underlying mortgage loans. Key properties include 681 Fifth Avenue, Potomac Mills, Fresno Fashion Fair, Hyatt Regency Jersey City, Easton Town Center, and 8 Times Square & 1460 Broadway, governed by PSAs such as MSC 2016-UBS12, CFCRE 2016-C6, and others. Several servicer transitions occurred in 2025 (e.g., March 1 for Trimont LLC succeeding Wells Fargo Bank in multiple roles; January 29 for Rialto Capital Advisors as special servicer), with no material non-compliance noted.

  • ·Servicer transitions: Wells Fargo Bank as master servicer prior to March 1, 2025, succeeded by Trimont LLC on/after March 1, 2025 (Potomac Mills, Easton Town Center, 8 Times Square & 1460 Broadway).
  • ·Special servicer changes: Midland to Rialto Capital Advisors on/after January 29, 2025 (Fresno Fashion Fair); Situs Holdings prior to June 24, 2025 (Easton Town Center).
CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-P410-Kneutralmateriality 5/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-P4 includes reports on assessment of compliance with servicing criteria (Form 33), attestation reports (Form 34), and servicer compliance statements (Form 35) from various servicers, trustees, custodians, and operating advisors for multiple mortgage loans including Park Place, Fed Ex properties, Embassy Suites Lake Buena Vista, Opry Mills, Hyatt Regency Huntington Beach Resort & Spa, Marriott Savannah Riverfront, 247 Bedford Avenue, and Marriott Midwest Portfolio. Key servicers include Wells Fargo Bank (master servicer until March 1, 2025), Trimont LLC (master servicer thereafter), LNR Partners, Rialto Capital Advisors, and others under PSAs such as CGCMT 2016-GC36, WFCM 2016-BNK1, and JPMCC 2016-JP3. No material non-compliance issues are indicated in the referenced exhibits.

  • ·Master servicer transition from Wells Fargo Bank, National Association to Trimont LLC on March 1, 2025 for multiple loans including Fed Ex properties, Hyatt Regency Huntington Beach Resort & Spa, Marriott Savannah Riverfront, 247 Bedford Avenue, Opry Mills, and Marriott Midwest Portfolio.
Investcorp Credit Management BDC, Inc.10-Kmixedmateriality 9/10

31-03-2026

Investcorp Credit Management BDC, Inc. (ICMB) reported total investment income of $17,396,235 for the twelve months ended December 31, 2025, up 49.7% from $11,622,757 in the prior twelve months ended December 31, 2024, primarily from higher interest income. However, total expenses rose to $15,393,000, leading to net investment income declining 39.5% to $1,904,774, while realized and unrealized losses on investments totaled $10,752,714, resulting in a net decrease in net assets from operations of $8,847,940 (vs. a $6,042,089 increase prior year) and NAV per share falling 21.2% to $4.25 from $5.39. Total net assets decreased 21.0% to $61,326,012 from $77,602,130, with shares trading at a 28-48% discount to NAV throughout 2025.

  • ·Distributions paid per common share of $0.52 for twelve months ended Dec 31, 2025 (vs. $0.24 prior year).
  • ·Earnings per share of $(0.61) for twelve months ended Dec 31, 2025 (vs. $0.42 prior year).
  • ·Weighted average shares outstanding: 14,421,798.
  • ·Net cash provided by operating activities: $11,650,825 for twelve months ended Dec 31, 2025 (vs. $(6,762,289) prior year).
  • ·Capital gains incentive fee examples range from $0.05 million to $0.7 million across illustrative years.
TruBridge, Inc.10-Kmixedmateriality 9/10

31-03-2026

TruBridge, Inc. reported total revenues of $346,836 thousand for the year ended December 31, 2025, up 1% YoY from $342,205 thousand in 2024, with Financial Health segment growing 2% to $221,657 thousand while Patient Care remained essentially flat at $125,179 thousand. The company achieved net income of $4,354 thousand, a turnaround from a $20,945 thousand loss in 2024, with operating income rising to $20,832 thousand from $6,371 thousand; however, total bookings were flat at $82,928 thousand and Patient Care recurring revenues declined to $109,370 thousand from $111,325 thousand. Adjusted EBITDA in Patient Care surged 51% to an unspecified amount implied by segment growth, but international sales showed minimal growth at $5,852 thousand.

  • ·Cash and cash equivalents increased to $24,850 thousand from $12,324 thousand YoY.
  • ·Total liabilities decreased to $224,567 thousand from $228,754 thousand.
  • ·Long-term debt decreased to $161,241 thousand from $168,598 thousand.
  • ·International sales from specific regions including St. Maarten, Turks and Caicos, Anguilla, Canada, England, Australia, UAE, and Netherlands totaled $5,852 thousand in 2025.
  • ·No goodwill or trademark impairments in 2025 vs $35,913 thousand and $2,342 thousand in 2023.
CITIGROUP COMMERCIAL MORTGAGE TRUST 2018-C610-Kneutralmateriality 5/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2018-C6, filed on March 31, 2026, contains multiple attestation reports (Form 34) and assessment reports (Form 33) affirming compliance with servicing criteria for asset-backed securities by various master servicers, special servicers, operating advisors, custodians, trustees, and servicing function participants. These reports cover mortgage loans such as DUMBO Heights Portfolio, Liberty Portfolio, 192 Lexington Avenue, Shelbourne Global Portfolio I, Moffett Towers—Buildings E, F, G, Riverwalk II, and Danbury Commerce Portfolio under PSAs including Benchmark 2018-B7, UBS 2018-C13, DBGS 2018-C1, and WFCM 2018-C48. Key servicer transitions noted include special servicer change for DUMBO Heights from Green Loan Services LLC to Torchlight Loan Services, LLC effective December 9, 2025, and master servicer shifts from Wells Fargo Bank to Trimont LLC effective March 1, 2025, for multiple loans, with all parties attesting to compliance.

  • ·Pooling and Servicing Agreement dated December 1, 2018 for WFCM 2018-C48 PSA referenced.
  • ·Benchmark 2018-B7 PSA, UBS 2018-C13 PSA, DBGS 2018-C1 PSA, and WFCM 2018-C48 PSA govern the listed mortgage loans.
Sequoia Mortgage Trust 2013-710-Kpositivemateriality 3/10

31-03-2026

Sequoia Mortgage Trust 2013-7 filed its 10-K annual report on March 31, 2026, including a report on compliance with servicing criteria under Rule 1122(d). All applicable criteria across multiple periods and servicers, including aggregation accuracy, pool asset payments, disbursements, advances, account maintenance, and safeguards, were affirmed as compliant with X marks. No exceptions or non-compliance were reported.

Tonix Pharmaceuticals Holding Corp.8-Kpositivemateriality 8/10

31-03-2026

Tonix Pharmaceuticals Holding Corp. (TNXP) announced positive Phase 1 data for TNX-4800, a long-acting monoclonal antibody for Lyme disease prevention, presented on March 30, 2026, at the World Vaccine Congress Washington 2026 by Mark S. Klempner, MD. The study in 44 healthy subjects demonstrated safety, tolerability, rapid absorption, and pharmacokinetics supporting approximately four months of protection, with mean serum levels of 10 μg/ml at four months in the 5 mg/kg cohort and quantifiable levels up to 12 months. The company outlined plans for an adaptive Phase 2 field study with a 350 mg fixed dose, targeting initiation in H1 2027 pending FDA clearance, with primary endpoint of Lyme prevention at four months.

  • ·Phase 1 doses tested: 0.5, 1.5, 5, or 10 mg/kg subcutaneous.
  • ·Mean half-life: 62-69 days across cohorts; maximum half-life 81-104 days.
  • ·Serum TNX-4800 quantifiable >200 days in 80% at lowest dose; up to 350 days at ≥1.5 mg/kg.
  • ·Phase 2 fixed dose: 350 mg subcutaneous, comparable to 5 mg/kg Phase 1 exposure.
  • ·Phase 2 participants: adolescents and adults aged 16-65 in U.S. Lyme-endemic areas.
  • ·GMP investigational product available early 2027; potential CHIM study in 2028 pending FDA clearance.
Telomir Pharmaceuticals, Inc.8-Kpositivemateriality 9/10

31-03-2026

On March 31, 2026, Telomir Pharmaceuticals, Inc. submitted an Investigational New Drug (IND) application to the FDA for its lead candidate Telomir-1 (Telomir-Zn), a first-in-class metal-modulating epigenetic therapy, targeting advanced and metastatic Triple-Negative Breast Cancer (TNBC). Preclinical studies demonstrated reduction in tumor growth, metastatic dissemination, and iron-dependent tumor cell mortality across TNBC models, supported by a favorable GLP safety profile with no treatment-related adverse or dose-limiting toxicities. Subject to FDA clearance, the company plans to initiate a Phase 1/2 clinical trial with a 3+3 dose-escalation in Phase 1 and Simon two-stage design in Phase 2, focusing on safety, tolerability, and objective response rate.

  • ·Telomir-1 modulates intracellular metal homeostasis by reducing redox-active iron and increasing zinc availability, inhibiting iron-dependent epigenetic enzymes like histone demethylases (KDMs).
  • ·Company continuing evaluation of Telomir-Zn in additional preclinical TNBC models and advancing biomarker strategies.
  • ·Scientific manuscripts submitted to peer-reviewed journals.
SideChannel, Inc.8-Kpositivemateriality 4/10

31-03-2026

SideChannel, Inc. issued a press release on March 31, 2026, announcing the integration of artificial intelligence into its sales, marketing, and cybersecurity delivery operations. The disclosure was made under Item 7.01 Regulation FD and furnished as Exhibit 99.1. No financial metrics or performance data were provided.

RANGE RESOURCES CORPDEF 14Apositivemateriality 8/10

31-03-2026

Range Resources Corporation's 2026 Proxy Statement summarizes strong 2025 financial performance, including $2.8B in natural gas, NGLs, and oil sales (up 11% YoY), $1.2B cash flows from operating activities, $832M income before income taxes, $231M share repurchases, and $86M dividends paid. The company reduced net debt by $186M, maintained a 0.8x Debt to EBITDAX ratio, and had $1.7B available under its credit facility at year-end. Operational highlights feature production growth of 19.8 bcfe versus 2024, 100% drilling success rate, and 18th consecutive year of positive reserve revisions, with no reported declines.

  • ·2026 Annual Meeting: May 13, 2026 at 8:00 a.m. Central Time, virtual at https://ir.rangeresources.com/events/event-details/2026-annual-meeting-stockholders; Record Date: March 16, 2026
  • ·Proposals: Election of 7 directors (Board recommends FOR), Advisory vote on executive compensation (FOR), Ratification of Ernst & Young LLP (FOR)
  • ·Board refreshment: Added 4 new directors since 2021 (3 independent), average tenure approximately 6 years
  • ·100% drilling success rate in 2025; 18th consecutive year of positive reserve performance revisions
Citigroup Commercial Mortgage Trust 2016-GC3710-Kneutralmateriality 4/10

31-03-2026

Citigroup Commercial Mortgage Trust 2016-GC37 filed its 10-K annual report on March 31, 2026, containing reports on assessments of compliance with servicing criteria and attestation reports from multiple servicers, including master servicers Wells Fargo Bank (prior to March 1, 2025) and Trimont LLC (on and after), special servicers like Midland Loan Services and Greystone Servicing Company LLC, operating advisors like Park Bridge Lender Services LLC, and others such as Citibank N.A., Berkadia Commercial Mortgage LLC, and Wilmington Trust for mortgage loans including Sheraton Denver Downtown Fee, Austin Block 21, 5 Penn Plaza, Park Place, 79 Madison Avenue, and 600 Broadway under PSAs like CGCMT 2016-GC36, CGCMT 2016-P3, and DBJPM 2016-C1. The filing incorporates by reference 2016 mortgage loan purchase agreements and subservicing agreements. No financial performance metrics, delinquencies, or material non-compliance issues are detailed in the provided content.

  • ·Master servicer transition from Wells Fargo Bank to Trimont LLC effective March 1, 2025 for certain loans (e.g., 79 Madison Avenue, 600 Broadway).
  • ·Mortgage Loan Purchase Agreements dated April 1, 2016, incorporated by reference from Form 8-K filed April 26, 2016.
Sequoia Mortgage Trust 2013-410-Kpositivemateriality 3/10

31-03-2026

The 10-K annual report for Sequoia Mortgage Trust 2013-4, filed on March 31, 2026, includes compliance assertions under Regulation AB 1122(d) for cash collection and administration. All listed criteria, including timely deposits, authorized disbursements, advances, account maintenance, and use of federally insured institutions, are marked compliant (X) across applicable periods with no exceptions noted.

Ares Management Corp8-Kpositivemateriality 8/10

31-03-2026

Ares Holdings L.P., a key subsidiary of Ares Management Corp, entered into a new Credit Agreement dated March 27, 2026, establishing a U.S. Dollar three-year delayed draw term loan facility with Bank of America, N.A. as administrative agent and BOFA Securities, Inc. as sole lead arranger and bookrunner. The agreement includes standard representations, covenants, and definitions such as Adjusted EBITDA with restrictions on fee inclusions (no more than 15% from Designated Subsidiaries or 5% from Unrestricted Subsidiaries), but no specific commitment amounts or draw details are provided in the filing excerpt.

  • ·Applicable Margin for Term SOFR Rate Loans ranges from 0.750% (Level I) to 1.250% (Level V) based on Ares Parent’s senior long-term unsecured debt ratings from S&P/Fitch/Moody’s.
  • ·Agreement filed as Exhibit 10.1 in 8-K on March 31, 2026 under Items 1.01, 2.03, 9.01.
DAWSON GEOPHYSICAL CO8-Kmixedmateriality 8/10

31-03-2026

Dawson Geophysical reported Q4 2025 fee revenue of $22.9 million, up 67% YoY, and full-year fee revenue of $61.9 million, up 16% YoY, driving Adjusted EBITDA to $3.3 million in Q4 (up 248%) and $4.7 million for the year (up 139%), alongside $14.0 million in operating cash flow. However, full-year revenue grew only 2% to $75.6 million, gross margins remained flat at 21%, and the company posted a net loss of $1.9 million (improved from $4.1 million in 2024). The company is in discussions with controlling shareholder Wilks Brothers, LLC (80% ownership) on potential transactions, incurring $0.5 million in related expenses.

  • ·Reimbursable revenue declined to $13.7M in FY 2025 from $20.7M in FY 2024.
  • ·Gross margin flat at 23% for Q4 and 21% for FY.
  • ·New $5M revolving credit facility entered in Oct 2025, no balance outstanding at year-end.
  • ·One large channel crew and three smaller in US Q4; resumed Canadian ops with two crews in Q4, three in Q1 2026.
  • ·Special Committee of independent directors formed to evaluate potential transactions with Wilks.
Red Cat Holdings, Inc.8-Kpositivemateriality 9/10

31-03-2026

Red Cat Holdings, Inc. entered into a Share Purchase Agreement on March 30, 2026, to acquire all issued and outstanding capital stock of Quaze Technologies, Inc. through its wholly-owned subsidiary 9563-4747 Quebec Inc. for approximately $25,000,000 in shares of Company common stock, subject to adjustments for indebtedness, transaction expenses, and net working capital. Additional earnout consideration of up to $5,000,000 in shares is payable upon achieving certain integration, revenue, and gross margin thresholds.

  • ·Acquisition closing subject to customary conditions including regulatory approvals, accuracy of representations and warranties, and continued Nasdaq listing of RCAT common stock.
  • ·Purchase Agreement terminable if closing conditions not met by December 31, 2026.
Red Cat Holdings, Inc.8-Kpositivemateriality 8/10

31-03-2026

Red Cat Holdings, Inc., a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, announced on March 30, 2026, its acquisition of the businesses of Apium Swarm Robotics, Inc. and Apium Inc., developers of distributed autonomy for unmanned systems. The press release detailing the transaction is attached as Exhibit 99.1.

RANGE IMPACT, INC.8-Kpositivemateriality 9/10

31-03-2026

Range Impact reported FY2025 financial results with revenues from continuing operations surging from $0 in 2024 to $3.7 million and net income improving from a $9.8 million loss to a $19.2 million gain (a $29.0 million YoY improvement), driven by bargain purchase gains and acquisitions. Total assets expanded from $6.2 million to $123.2 million, and shareholders' equity grew from $0.8 million to $37.8 million, fueled by acquiring two large coal mine complexes that increased mineral interests from 50 acres to over 150,000 acres and surface land from 1,800 acres to approximately 30,000 acres. However, these acquisitions added ownership or management of 76 mining permits along with $79.3 million in estimated future reclamation obligations.

  • ·Divestiture of non-core reclamation services business for third parties
  • ·Net operating loss carryforwards of $23.5 million federal and $18.4 million state as of Dec 31, 2025
  • ·Reduced bond obligations at the Fola Mine by $2.3 million during 2025
  • ·Annual Report on Form 10-K filed March 30, 2026
FIRST NORTHERN COMMUNITY BANCORP8-Kpositivemateriality 7/10

31-03-2026

First Northern Community Bancorp announced a new stock repurchase program approved by its Board of Directors effective March 26, 2026, set to begin on May 1, 2026, and remain in effect until April 30, 2028. The program authorizes repurchases of up to 6% of its 16,409,660 outstanding common shares as of March 26, 2025, equating to 984,579 shares, or approximately $15.6M at the March 26, 2026 closing price of $15.85 per share. The Board determined that maximum repurchases will not impair the company's capital, with transactions to comply with SEC Rule 10b-18.

  • ·Press release issued March 30, 2026 and furnished as Exhibit 99.1
  • ·Repurchases may be made in open market or privately negotiated transactions based on market conditions
Benchmark 2026-V20 Mortgage Trust8-Kneutralmateriality 7/10

31-03-2026

BMO Commercial Mortgage Securities LLC, as Depositor, executed a Pooling and Servicing Agreement dated as of March 1, 2026, for the BMO 2026-5C14 Mortgage Trust, establishing the framework for Commercial Mortgage Pass-Through Certificates, Series 2026-5C14, including conveyance of mortgage loans, servicing duties, and distributions to certificateholders. Key service providers include Midland Loan Services, a division of PNC Bank, N.A. (Master Servicer), CWCapital Asset Management LLC (Special Servicer), Pentalpha Surveillance LLC (Operating Advisor and Asset Representations Reviewer), and Computershare Trust Company, N.A. (Certificate Administrator and Trustee). The agreement details administrative, servicing, and compliance provisions with no specific financial performance metrics or period-over-period comparisons disclosed.

  • ·No Class S Certificates, Class VRR Certificates, or Loan-Specific Certificates will be issued under this Agreement
  • ·Agreement filed as Exhibit 99.1 in 8-K on March 31, 2026
SmartStop Self Storage REIT, Inc.8-Kpositivemateriality 6/10

31-03-2026

On March 29, 2026, the Board of Directors of SmartStop Self Storage REIT, Inc. declared a monthly dividend for April 2026 of $0.13150685 per share of common stock, reflecting a targeted annualized dividend of $1.60 per share. The record date is April 30, 2026, with payment on May 15, 2026. No other financial metrics or comparisons were disclosed.

  • ·Filing signed on March 30, 2026
  • ·Securities: Common Stock, $0.001 par value, trading symbol SMA on New York Stock Exchange
Range Acquisition Corp.10-Kneutralmateriality 5/10

31-03-2026

Range Acquisition Corp., incorporated on July 3, 2025, reported no revenue and a net loss of $22,429 for the period ended December 31, 2025, driven entirely by general and administrative expenses of $22,429. Total assets stood at $16,416, consisting solely of cash, while total liabilities were $37,845, including a $29,250 note payable to a stockholder and $8,595 in accounts payable, resulting in a stockholders’ deficit of $21,429. Financing activities provided $30,250, primarily from the stockholder note, with net cash used in operations at $13,834.

  • ·Preferred stock: 10,000,000 shares authorized, none issued.
  • ·Common stock: $0.0001 par value, 50,000,000 shares authorized.
  • ·Report of Independent Registered Public Accounting Firm (PCAOB ID: 606).
CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-P510-Kneutralmateriality 4/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-P5, filed March 31, 2026, consists of multiple attestation reports (Exhibit 34 series) and compliance assessments (Exhibit 33 and 35 series) from servicers, trustees, custodians, and operating advisors affirming compliance with servicing criteria for asset-backed securities across various mortgage loans under PSAs such as CGCMT 2016-P4, JPMCC 2016-JP3, and others. A key change noted is the transition of master servicer duties from Wells Fargo Bank, National Association to Trimont LLC effective March 1, 2025 for several loans including Esplanade I, Opry Mills, Vertex Pharmaceuticals HQ, Flagler Corporate Center, and Plaza America I & II. No financial performance metrics, period-over-period comparisons, or material issues are disclosed in the provided content.

  • ·Servicing function transitions effective March 1, 2025 from Wells Fargo to Trimont LLC for loans under WFCM 2016-BNK1, MSBAM 2016-C30, JPMCC 2016-JP2, CGCMT 2016-P4, and WFCM 2016-C36 PSAs
  • ·Greystone Servicing Company LLC acts as successor to C-III Asset Management LLC for certain special servicing roles
CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-C310-Kneutralmateriality 4/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-C3, filed on March 31, 2026, contains numerous attestation reports and assessments of compliance with servicing criteria for asset-backed securities from various master servicers, special servicers, operating advisors, custodians, trustees, and other participants across multiple mortgage loans, including 101 Hudson Street, Potomac Mills, Hill7 Office, Marriott Hilton Head Resort & Spa, Briarwood Mall, and College Boulevard Portfolio. Several reports note a master servicer transition on March 1, 2025, from Wells Fargo Bank, National Association to Trimont LLC for loans under PSAs such as MSC 2016-BNK2, CFCRE 2016-C6, MSBAM 2016-C30, and WFCM 2016-LC25. No financial performance metrics, delinquencies, or non-compliance issues are detailed in the provided content.

  • ·Servicer transitions effective March 1, 2025: Wells Fargo Bank to Trimont LLC as master servicer for multiple loans (e.g., under MSC 2016-BNK2, CFCRE 2016-C6, MSBAM 2016-C30, WFCM 2016-LC25 PSAs)
  • ·PSAs referenced: MSC 2016-BNK2, CFCRE 2016-C6, WFCM 2016-LC25, MSBAM 2016-C30, CGCMT 2016-P5
CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-GC3610-Kpositivemateriality 4/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-GC36 contains servicing compliance assertions under Regulation AB Rule 1122(d) from servicers including KeyBank, Berkadia, and Midland, confirming that most applicable servicing criteria were performed directly or via responsible vendors. While many criteria across general servicing, cash collection, investor reporting, and pool asset administration are marked as compliant (X), several are noted as N/A or not performed, such as certain investor remittance processes, backup servicer maintenance, and specific loss mitigation or escrow handling. No material non-compliance or deficiencies are disclosed.

  • ·Compliance assessed for reporting period ending prior to March 31, 2026 filing.
  • ·Multiple criteria marked N/A for investor remittances (1122(d)(3)(ii)-(iv)) and certain pool asset records (1122(d)(4)(v), (ix)-(xv)).
  • ·Backup servicer maintenance (1122(d)(1)(iii)) not performed by some asserting parties.
CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-C210-Kneutralmateriality 4/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-C2, filed on March 31, 2026, contains numerous attestation reports and servicer compliance statements assessing compliance with servicing criteria for asset-backed securities across multiple mortgage loans. Key servicers including Wells Fargo Bank (prior to March 1, 2025), Trimont LLC (on/after March 1, 2025), LNR Partners, Midland Loan Services, and others provided reports for properties such as Hyatt Regency Huntington Beach Resort & Spa, Kroger (Roundy’s) Distribution Center, Vertex Pharmaceuticals HQ, Opry Mills, Jay Scutti Plaza, and Staybridge Suites Times Square. No quantitative financial performance data or material non-compliance issues are detailed in the provided content.

  • ·Servicer transitions occurred on March 1, 2025, from Wells Fargo Bank to Trimont LLC as master/general master servicer for multiple loans (e.g., Hyatt Regency, Kroger, Vertex, Opry Mills).
  • ·Referenced PSAs include CGCMT 2016-C1, WFCM 2016-C35, CSAIL 2016-C6, WFCM 2016-BNK1, JPMCC 2016-JP2, DBJPM 2016-C3.
Citigroup Commercial Mortgage Trust 2016-C110-Kneutralmateriality 4/10

31-03-2026

The 10-K filing for Citigroup Commercial Mortgage Trust 2016-C1 provides extensive attestation reports (Exhibit 34 series), compliance assessment reports (Exhibit 33 series), and servicer compliance statements (Exhibit 35 series) from multiple parties including master servicers, special servicers, trustees, custodians, and operating advisors, affirming compliance with servicing criteria for asset-backed securities across various mortgage loans. Covered loans include Madbury Commons (CFCRE 2016-C4 PSA), Park Place (CGCMT 2016-GC36 PSA), Embassy Suites Lake Buena Vista (JPMCC 2016-JP3 PSA), and OZRE Leased Fee Portfolio (CFCRE 2016-C6 PSA). A master servicer transition from Wells Fargo Bank, National Association to Trimont LLC occurred on March 1, 2025 for certain loans, with separate reports for pre- and post-transition periods.

  • ·Mortgage Loan Purchase Agreements dated May 1, 2016, incorporated by reference from June 1, 2016 Form 8-K.
  • ·Filing incorporates prior exhibits via cross-references (e.g., Exhibit 34.7 referenced multiple times).
CITIGROUP COMMERCIAL MORTGAGE TRUST 2020-GC4610-Kneutralmateriality 4/10

31-03-2026

The 10-K annual report for CITIGROUP COMMERCIAL MORTGAGE TRUST 2020-GC46, filed on March 31, 2026, contains extensive attestation reports (Exhibit 34 series) and compliance assessment reports (Exhibit 33 series) from master servicers, special servicers, operating advisors, custodians, trustees, and other parties confirming adherence to servicing criteria for asset-backed securities across multiple underlying mortgage loans. Covered properties include The Shoppes at Blackstone Valley, Parkmerced, Bellagio Hotel and Casino, 650 Madison Avenue, 1633 Broadway, Southcenter Mall, 90 North Campus, Property Commerce Portfolio, 510 East 14th Street, 805 Third Avenue, and 405 E 4th Avenue, serviced under various PSAs and TSAs such as COMM 2019-GC44, MRCD 2019-PARK, and GSMS 2020-GC45. No material non-compliance issues or performance variances are noted in the listed reports.

  • ·Servicer transitions noted: 3650 REIT Loan Servicing LLC as special servicer prior to September 5, 2025, succeeded by Green Loan Services LLC; Wells Fargo Bank as master servicer prior to March 1, 2025 under CGCMT 2019-C7 PSA, succeeded by Trimont LLC
GUIDED THERAPEUTICS INC10-Kmixedmateriality 8/10

31-03-2026

Guided Therapeutics Inc's 10-K for the year ended December 31, 2025, shows sales surging to $767 thousand from just $7 thousand in 2024, yielding a gross profit of $571 thousand versus $2 thousand. However, the net loss attributable to common stockholders widened to $3,346 thousand from $2,591 thousand, driven by a 39% rise in operating expenses to $2,943 thousand, particularly G&A costs jumping to $2,305 thousand, while cash dwindled 84% to $63 thousand and stockholders' deficit expanded to $6,006 thousand. Total assets edged down to $1,324 thousand amid ongoing high indebtedness of $7,330 thousand.

  • ·Regulatory approval for LuViva granted in Russia in 2025.
  • ·Common shares outstanding increased 32% to 86,154 from 65,131.
  • ·Trade receivables net increased slightly to $4 thousand from $3 thousand.
  • ·Inventory declined to $448 thousand from $633 thousand.
BMO 2024-C8 Mortgage Trust10-Kneutralmateriality 4/10

31-03-2026

BMO 2024-C8 Mortgage Trust filed its 10-K annual report on March 31, 2026, featuring extensive attestation reports (Exhibit 34 series) and reports on assessments (Exhibit 33 series) confirming compliance with servicing criteria for asset-backed securities by multiple servicers, trustees, custodians, and operating advisors. These cover mortgage loans including 60 Hudson, Arundel Mills and Marketplace, Axis Apartments, Woodfield Mall, and OPI Portfolio under PSAs such as MSWF 2023-2, Benchmark 2023-B40, BMO 2023-C7, and BMO 2024-5C3. Servicer compliance statements (Exhibit 35 series) are also included, noting transitions such as Wells Fargo Bank to Trimont LLC as master servicer effective March 1, 2025, and other changes.

  • ·Pooling and Servicing Agreement (BMO 2024-5C3 PSA) dated February 1, 2024.
  • ·Midland Loan Services appointed special servicer on and after March 10, 2025 under BMO 2024-5C3 PSA.
FinTrade Sherpa, Inc.10-Kmixedmateriality 6/10

31-03-2026

FinTrade Sherpa, Inc. reported no revenue in 2025 or 2024, with net loss expanding significantly to $341,856 from $79,052, reflecting a 332% increase in operating expenses to $341,856 driven by new research and development costs of $123,120, license payments of $20,000, and higher professional fees. However, the company improved its cash position slightly to $1,625 from $1,175, narrowed stockholders’ deficiency to $(120,713) from $(168,502), and generated $283,617 from financing activities including share issuances. Working capital deficiency remained essentially flat at $(168,918) versus $(168,502).

  • ·Professional fees increased to $171,683 in 2025 from $54,692 in 2024.
  • ·Accounts payable and accrued liabilities rose to $131,667 from $24,773.
  • ·Due to related parties decreased to $38,876 from $144,904.
  • ·Total assets increased to $49,830 from $1,175 primarily due to deferred acquisition costs.
  • ·Cash flows from investing activities used $48,205 for deferred acquisition costs.
  • ·Proceeds from related party advances $63,617; shares issued for $220,000 cash.
Benchmark 2023-V4 Mortgage Trust10-Kneutralmateriality 4/10

31-03-2026

The 10-K annual report for Benchmark 2023-V4 Mortgage Trust, filed March 31, 2026, contains servicing compliance assertions from Midland, K-Star, PBLS, and Berkadia under Regulation AB 1122(d) servicing criteria. Most criteria are reported as performed directly by the servicers or via responsible vendors, with some marked N/A or not performed by specific servicers due to divided roles; however, several investor reporting and pool asset administration criteria are noted as not performed by K-Star, PBLS, or their vendors. No material instances of noncompliance or exceptions are disclosed.

  • ·Compliance assertions cover the reporting period ending prior to March 31, 2026 filing
  • ·Multiple criteria marked N/A (e.g., back-up servicer requirements, external enhancements) across servicers
  • ·K-Star and PBLS report numerous criteria as 'NOT performed by K-Star/PBLS or their subservicers/vendors', including most investor remittances
BENCHMARK 2020-B19 MORTGAGE TRUST10-Kneutralmateriality 5/10

31-03-2026

The 10-K annual report for Benchmark 2020-B19 Mortgage Trust, filed on March 31, 2026, contains extensive lists of Exhibit 33 and 34 reports and attestation reports on compliance with servicing criteria for asset-backed securities from multiple servicers, trustees, custodians, and operating advisors. These reports cover servicing of various mortgage loans including the Agellan Portfolio, 420 Taylor Street, Brass Professional Center, 280 North Bernardo, Moffett Place – Building 6, Moffett Towers Buildings A, B & C, 1633 Broadway, 675 Creekside Way, The Shoppes at Blackstone Valley, 711 Fifth Avenue, BX Industrial Portfolio, and MGM Grand & Mandalay Bay under PSAs such as Benchmark 2020-B18, MOFT 2020-B6, and others. No financial performance metrics or non-compliance issues are detailed in the provided content.

  • ·Servicer transitions noted: Wells Fargo Bank as servicer prior to March 1, 2025; Trimont LLC as servicer on and after March 1, 2025 for certain loans (e.g., MOFT 2020-ABC, GSMS 2020-GC47)
BENCHMARK 2021-B31 MORTGAGE TRUST10-Kneutralmateriality 3/10

31-03-2026

The 10-K annual report for Benchmark 2021-B31 Mortgage Trust, filed March 31, 2026, consists primarily of listings of attestation reports and assessments on compliance with servicing criteria for asset-backed securities from multiple parties including master servicers, special servicers, operating advisors, custodians, trustees, and servicing function participants. These reports pertain to specific mortgage loans such as CX – 350 & 450 Water Street, One Memorial Drive, Equus Industrial Portfolio, The Veranda, Audubon Crossings & Commons, and Plaza La Cienega, serviced under agreements like CAMB 2021-CX2 TSA, JPMCC 2021-1MEM TSA, Benchmark 2021-B30 PSA, and 3650R 2021-PF1 PSA. No quantitative financial data, performance metrics, or non-compliance issues are detailed in the provided exhibit listings.

RANGE IMPACT, INC.10-Kmixedmateriality 9/10

31-03-2026

Range Impact, Inc. (RNGE) reported total assets surging to $123,236,692 from $6,192,715 YoY, fueled by a major acquisition adding $42,548,402 in land and $77,814,610 in intangibles, resulting in net income of $19,167,678 versus a $9,798,083 loss in 2024, with stockholders’ equity rising to $37,789,579 from $834,405. However, revenues of $3,710,714 were outweighed by $5,450,578 in costs and expenses, yielding a $1,739,864 loss from continuing operations before a $21,928,500 bargain purchase gain, while operating cash flow was only modestly positive at $123,028 versus a $1,591,426 outflow prior year. Fixed asset impairments totaled $831,027, and interest expense remained high at $252,279.

  • ·Noncontrolling equity interest recorded at $16,326,016 related to acquisition.
  • ·Gain on bargain purchase adjusted by $16,326,016 for noncontrolling interest.
  • ·Initial asset retirement obligation recorded at $79,701,104.
  • ·Line of credit of $1,800,000 converted to term bank debt.
  • ·Bank debt current portion $400,000 and long-term $1,400,000 as of Dec 31 2025.
  • ·Accounts payable increased to $1,136,907 from $335,120 YoY.
  • ·Accrued expenses rose to $2,165,909 from $161,832 YoY.
SUIC Worldwide Holdings Ltd.10-Kmixedmateriality 7/10

31-03-2026

SUIC Worldwide Holdings Ltd. reported its first-ever revenue of $18,482 in 2025, generating gross profit of $11,382, while total operating expenses declined 50% YoY to $109,719, narrowing the net loss to $119,644 from $234,211. Loss from operations improved to $(98,337) from $(217,623). However, total assets shrank to $9,791 from $84,197, cash dropped to $8,560 from $38,495, liabilities rose slightly to $887,755, and stockholders' deficiency deepened to $(877,964) from $(773,550).

  • ·Cash flow from operating activities improved to $(46,620) from $(174,245) YoY.
  • ·Net cash from financing activities $16,685 in 2025 vs $205,140 in 2024.
  • ·Convertible promissory notes unchanged at $279,000.
  • ·No income taxes paid; full valuation allowance on deferred tax assets.
  • ·Earnings per share $0.00 for both years.
Benchmark 2023-B39 Mortgage Trust10-Kneutralmateriality 4/10

31-03-2026

The 10-K annual report for Benchmark 2023-B39 Mortgage Trust, filed March 31, 2026, contains servicing criteria compliance assertions under Regulation AB from multiple servicers including Midland, K-Star, PBLS, Special Servicer, and KeyBank. Most applicable criteria are reported as performed directly by the servicers or by vendors for which they are responsible, with several marked as N/A or not performed where inapplicable to their roles. No material deficiencies or non-compliance issues are disclosed.

  • ·Multiple criteria designated N/A (e.g., back-up servicer maintenance, investor reporting specifics) across servicers.
  • ·Certain criteria NOT performed by specific servicers (e.g., K-Star not responsible for investor remittances; PBLS not performing most cash collection tasks).
BENCHMARK 2022-B35 MORTGAGE TRUST10-Kpositivemateriality 5/10

31-03-2026

The 10-K filing for BENCHMARK 2022-B35 MORTGAGE TRUST includes Item 1122 assertions from servicers KeyBank, PBLS, Midland, and Berkadia confirming compliance with applicable Regulation AB servicing criteria related to general servicing, cash collection, investor remittances, and pool asset administration. Most criteria are marked as performed directly by the servicers or by responsible vendors, with several designated as N/A and no material non-compliance or exceptions reported. This routine compliance report provides assurance on servicing activities without highlighting any deficiencies.

  • ·Filing date: March 31, 2026
  • ·Multiple servicers assert no material servicing deficiencies for the reporting period
BMO 2023-5C2 Mortgage Trust10-Kpositivemateriality 4/10

31-03-2026

The 10-K filing for BMO 2023-5C2 Mortgage Trust includes servicer compliance assertions under Regulation AB Item 1122 from KeyBank, Midland, K-Star, and platform servicers, confirming adherence to nearly all applicable servicing criteria such as policies for monitoring defaults, cash handling, reconciliations, and pool asset administration. Most criteria are marked as performed directly by servicers or responsible vendors, with several designated as N/A where not applicable to the transaction. No non-compliance issues or exceptions are reported.

Citigroup Commercial Mortgage Trust 2022-GC4810-Kpositivemateriality 4/10

31-03-2026

The 10-K annual report for Citigroup Commercial Mortgage Trust 2022-GC48, filed on March 31, 2026, details compliance assessments for Regulation AB servicing criteria (1122(d)) by servicers including Midland, KeyBank, and PBLS across multiple platforms. All applicable criteria are affirmed as performed directly by the servicers or by vendors for which they are responsible, with certain criteria marked N/A or inapplicable depending on the servicer or platform. No servicing deficiencies, exceptions, or material issues are reported.

ATA Creativity Global20-Fmixedmateriality 8/10

31-03-2026

ATA Creativity Global reported consolidated net revenues of RMB 268,112,876 for the year ended December 31, 2025, essentially flat YoY at 0.02% growth from RMB 268,060,162 in 2024, while revenues had grown 21% from RMB 221,618,968 in 2023. However, net loss attributable to ATA widened 33.1% YoY to RMB 48,047,494 from RMB 36,097,777, driven by a RMB 33,908,719 goodwill impairment, higher operating expenses, and loss from operations increasing 49% to RMB 64,110,700. In January 2026, the company completed a registered direct offering of 11,067,547 ADSs and relevant CSRC filing, amid ongoing PRC regulatory risks on dividends, foreign exchange, and VIE structures.

  • ·All PRC subsidiaries and VIE hold required Business Licenses; CSRC filing completed for Jan 2026 ADS offering.
  • ·PRC regulations require allocation of at least 10% of after-tax profits to statutory reserves until reaching 50% of registered capital, restricting dividend payments.
  • ·Foreign exchange controls may limit remittance of RMB out of China for dividends or debt service without approvals.
BENCHMARK 2018-B3 COMMERCIAL MORTGAGE TRUST10-Kneutralmateriality 3/10

31-03-2026

The 10-K annual report for Benchmark 2018-B3 Commercial Mortgage Trust includes multiple reports and attestation reports on compliance with servicing criteria for asset-backed securities from various servicers, trustees, custodians, and operating advisors. These cover mortgage loans such as 90 Hudson, 315 West 36th Street, InterContinental San Francisco, Rochester Hotel Portfolio, 599 Broadway, The SoCal Portfolio, Twelve Oaks Mall, and Marina Heights State Farm under multiple PSAs including Benchmark 2018-B1, COMM 2018-COR3, and others. No financial performance metrics, delinquencies, or non-compliance issues are disclosed in the provided tables.

  • ·Servicer transitions occurred on March 1, 2025: Wells Fargo Bank to Trimont LLC as master servicer for 90 Hudson (Benchmark 2018-B1 PSA) and Twelve Oaks Mall (GSMS 2018-GS9 PSA).
Welsbach Technology Metals Acquisition Corp.8-K/Amixedmateriality 9/10

31-03-2026

Evolution Metals & Technologies Corp. (EMAT, formerly Welsbach Technology Metals Acquisition Corp.) filed this Amendment No. 2 to Form 8-K on March 31, 2026, to report the completion of its Business Combination with Evolution Metals LLC (EM) on January 5, 2026, through which EM acquired Korean subsidiaries KCM Industry Co., Ltd., KMMI INC., NS World Co., Ltd., and Handa Lab Co., Ltd. The filing includes audited financial statements and MD&A for EMAT, EM, and the subsidiaries for the years ended December 31, 2025 and 2024, as well as unaudited pro forma condensed combined financial information for the year ended December 31, 2025. Multiple auditor reports note substantial doubt about the going concern ability of EMAT, EM, and certain subsidiaries.

  • ·Auditor consents from UHY LLP, Grassi & Co., CPAs, P.C., and Ernst & Young Han Young include explanatory paragraphs on going concern doubts for EMAT, EM, KCM, KMMI, NS World, and Handa Lab.
  • ·EMAT is an emerging growth company; common stock trades as EMAT on Nasdaq Stock Market LLC.
  • ·EM inception date: February 8, 2024.
Artificial Intelligence Technology Solutions Inc.8-Kpositivemateriality 4/10

31-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 31, 2026, announcing the issuance of a press release regarding its RAD division hosting its first global sales meeting to advance international expansion following a strong showing at ISC West. The press release is furnished as Exhibit 99.1 and is not deemed filed.

iShares S&P GSCI Commodity-Indexed Trust8-Kneutralmateriality 6/10

31-03-2026

On March 27, 2026, Jay Jacobs was appointed to the Board of Directors of iShares Delaware Trust Sponsor LLC (the Sponsor of iShares S&P GSCI Commodity-Indexed Trust) and as its President and Chief Executive Officer, replacing Shannon Ghia who resigned from those positions effective the same date. Ms. Ghia's resignation was not due to any dispute or disagreement with the Sponsor or Trust. Mr. Jacobs, a Managing Director at BlackRock, Inc., has extensive experience in ETFs, including as U.S. Head of Equity ETFs since April 7, 2025.

  • ·Jay Jacobs joined BlackRock as U.S. Head of Thematics and Active Equity ETFs on April 18, 2022.
  • ·From May 2013 to March 2022, Jay Jacobs worked at Global X ETFs, founding and leading its research and strategy team.
  • ·Jay Jacobs was a business analyst at the New York Stock Exchange from July 2011 to May 2013.
  • ·Jay Jacobs holds a BA in International Studies from Emory University, an MBA from Columbia Business School, and is a CFA charterholder.
UNITED SECURITY BANCSHARES8-Kpositivemateriality 10/10

31-03-2026

United Security Bancshares held a special shareholder meeting on March 30, 2026, with 12,019,562 shares represented, constituting 68.27% quorum of 17,604,923 outstanding shares. Shareholders overwhelmingly approved the merger agreement with Community West Bancshares (11,928,445 for, 65,144 against, 25,973 abstain) and the adjournment proposal if needed (11,880,814 for, 98,285 against, 40,463 abstain), with no broker non-votes. The merger agreement is dated December 16, 2025.

  • ·No broker non-votes recorded for either proposal
  • ·Filing signed on March 31, 2026
LIPELLA PHARMACEUTICALS INC.8-Knegativemateriality 10/10

31-03-2026

Lipella Pharmaceuticals Inc. and certain subsidiaries filed voluntary petitions for Chapter 11 bankruptcy relief in the United States Bankruptcy Court for the Western District of Pennsylvania on March 30, 2026. The filing warns that trading in the company's common stock during the Chapter 11 proceedings is highly speculative and carries substantial risks, with stock prices potentially unrelated to any shareholder recovery.

  • ·Registrant is an emerging growth company.
  • ·No securities registered pursuant to Section 12(b) of the Act.
  • ·Exhibit 99.1: Press Release dated March 30, 2026.
Citigroup Commercial Mortgage Trust 2015-GC2710-Kneutralmateriality 3/10

31-03-2026

The 10-K annual report for Citigroup Commercial Mortgage Trust 2015-GC27, filed on March 31, 2026, includes multiple exhibits detailing assessments and attestations of compliance with servicing criteria for asset-backed securities by various servicers and participants. Key exhibits cover reports from entities such as Northmarq Capital, LLC, Wells Fargo Bank (master servicer prior to March 1, 2025), Trimont LLC (master servicer on and after March 1, 2025), Rialto Capital Advisors, LLC (special servicer), and others including Park Bridge Lender Services LLC, Citibank N.A., Deutsche Bank Trust Company Americas, and CoreLogic Solutions, LLC. Servicer compliance statements are also provided for Wells Fargo and Trimont.

  • ·Master servicer transition from Wells Fargo Bank, National Association to Trimont LLC effective March 1, 2025
Citigroup Commercial Mortgage Trust 2014-GC2310-Kneutralmateriality 4/10

31-03-2026

The 10-K annual report for Citigroup Commercial Mortgage Trust 2014-GC23, filed on March 31, 2026, lists reports on assessments of compliance with servicing criteria for asset-backed securities (Exhibits 33.x) and attestation reports (Exhibits 34.x) from entities including Citibank N.A. (certificate administrator), Deutsche Bank Trust Company Americas (trustee and custodian), Midland Loan Services (master servicer), and Rialto Capital Advisors (special servicer). It also includes servicer compliance statements (Exhibits 35.x) and notes a master servicer transition on March 1, 2025, for the Selig Portfolio mortgage loan under the GSMS 2014-GC22 PSA from Wells Fargo Bank to Trimont LLC. No financial performance metrics, delinquencies, or material issues are detailed in the provided content.

Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 50 filings

🇺🇸 More from United States

View all →
Not Found | Gunpowder Blog